Enoxaparin
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Deep Vein Thrombosis
Conditions
Deep Vein Thrombosis, Pulmonary Embolism
Trial Timeline
May 1, 2006 → Dec 1, 2008
NCT ID
NCT00413374About Enoxaparin
Enoxaparin is a pre-clinical stage product being developed by Sanofi for Deep Vein Thrombosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00413374. Target conditions include Deep Vein Thrombosis, Pulmonary Embolism.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (11)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04492254 | Phase 3 | Terminated |
| NCT00908960 | Phase 2 | Completed |
| NCT00518245 | Approved | Terminated |
| NCT00622115 | Phase 1 | Completed |
| NCT00723216 | Phase 3 | Completed |
| NCT00444652 | Approved | UNKNOWN |
| NCT00769873 | Phase 2 | Terminated |
| NCT00413374 | Pre-clinical | Completed |
| NCT00265993 | Approved | Completed |
| NCT00043784 | Phase 3 | Completed |
| NCT00289042 | Approved | Completed |
Competing Products
20 competing products in Deep Vein Thrombosis